Stock data
Jade Biosciences, Inc. (JBIO)
Jade Biosciences, Inc. (JBIO) reported net income of -US$127.41M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$113.54M | -US$127.41M | — |
| 2024 | — | — | -US$74.60M | -US$69.63M | — |
| 2023 | — | — | -US$81.41M | -US$75.52M | — |
| 2022 | — | — | -US$53.24M | -US$51.51M | — |
| 2021 | — | — | -US$23.02M | -US$22.96M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$55.77M | — |
| 2026-03-31 | — | -US$40.37M | — |
| 2025-12-31 | — | -US$31.93M | — |
| 2025-09-30 | — | -US$25.18M | — |
| 2025-06-30 | — | -US$32.13M | — |
| 2025-03-31 | — | -US$38.17M | — |
| 2024-12-31 | — | -US$5.39M | — |
| 2024-09-30 | — | -US$16.28M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.